Page last updated: 2024-08-25

methotrexate and Hypomenorrhea

methotrexate has been researched along with Hypomenorrhea in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (50.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Espirito, JL; Games, DM; McCune, JS	1
Geiger, W; Künzig, HJ; Schmidt-Rhode, P; Schulz, KD; Weymar, P	1
Jaffe, N	1
Wells, AU	1

Reviews

1 review(s) available for methotrexate and Hypomenorrhea

Article	Year
Late side effects of treatment: skeletal, genetic, central nervous system, and oncogenic. Pediatric clinics of North America, 1976, Volume: 23, Issue:1 Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antineoplastic Agents; Busulfan; Carcinogens; Central Nervous System Diseases; Chemical and Drug Induced Liver Injury; Child; Female; Heart Diseases; Humans; Lung Diseases; Male; Menstruation Disturbances; Mercaptopurine; Methotrexate; Neoplasms; Neoplasms, Radiation-Induced; Pregnancy; Radiotherapy; Urinary Bladder Diseases	1976

Article

Year

Late side effects of treatment: skeletal, genetic, central nervous system, and oncogenic.

Pediatric clinics of North America, 1976, Volume: 23, Issue:1

Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antineoplastic Agents; Busulfan; Carcinogens; Central Nervous System Diseases; Chemical and Drug Induced Liver Injury; Child; Female; Heart Diseases; Humans; Lung Diseases; Male; Menstruation Disturbances; Mercaptopurine; Methotrexate; Neoplasms; Neoplasms, Radiation-Induced; Pregnancy; Radiotherapy; Urinary Bladder Diseases

1976

Other Studies

3 other study(ies) available for methotrexate and Hypomenorrhea

Article	Year
Assessment of ovarian failure and osteoporosis in premenopausal breast cancer survivors. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2005, Volume: 11, Issue:2 Topics: Absorptiometry, Photon; Administration, Oral; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Breast Neoplasms; Calcium; Contraceptives, Oral; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Utilization Review; Estradiol; Female; Fluorouracil; Follicle Stimulating Hormone; Follow-Up Studies; Goserelin; Humans; Medical Records; Menstruation Disturbances; Methotrexate; Osteoporosis, Postmenopausal; Premenopause; Primary Ovarian Insufficiency; Process Assessment, Health Care; Retrospective Studies; Survivors; Tamoxifen; Time Factors	2005
The effect of combination chemotherapy on ovarian, hypothalamic and pituitary function in patients with breast cancer. Archives of gynecology, 1979, Volume: 227, Issue:4 Topics: Adult; Amenorrhea; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follicle Stimulating Hormone; Humans; Hypothalamus; Luteinizing Hormone; Menopause; Menstruation Disturbances; Methotrexate; Middle Aged; Ovary; Pituitary Gland	1979
Corticosteroid induced osteoporosis in severe menstrual asthma. Steroid sparing drugs may be useful. BMJ (Clinical research ed.), 1992, Aug-15, Volume: 305, Issue:6850 Topics: Adult; Asthma; Female; Humans; Menstruation Disturbances; Methotrexate; Osteoporosis; Prednisolone	1992